Search Results

SOHM, Inc. announces today the collaboration with Coastar Therapeutics, announce their collaboration to advance the field of genome editing using Coastar’s red blood cell membrane derived carriers and SOHM’s ABBIE (A Binding Based Integrase Enzyme) genome editing technology.

SOHM, Inc., a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced its new manufacturing facility at Carlsbad.

SOHM, Inc. (OTC PINK: SHMN) (the “Company”) announces today the Company has filed a provisional patent application on its ABBIE “Smart Gene-Editing” platform that uses the latest enzymes and guide RNAs to resolve off-target gene-editing limitations.

SOHM has entered into development collaboration with the University of Arizona Center for Innovation to propel ABBIE, a non-viral gene-editing kit technology.

SOHM, Inc. announces that the company has signed a letter of intent to acquire stem cell disruptive technology and patents called “ABBIE.”

SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has acquired, ABBIE, a world-class gene-editing platform which can deliver genetic payloads using non-viral vectors.

SOHM, Inc., a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces that it has signed a memorandum of understanding with SRAM & MRAM Group for injections of required funds for the Company’s various new pipeline projects.

SOHM, Inc. to take advantage of the FDA converting more prescription Products to the over-the-counter Markets.

SOHM, Inc. (OTC PINK:SHMN), a generic pharmaceutical, nutraceutical, and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today its outlook for the year 2021. Mr. Baron Night, CEO, announced today that the company management is very happy with the performance of Q1 financials.